Last quarter (Q3 2023), NovoCure's total revenue was $127.32M, a decrease of -2.81% from the same quarter last year. In Q3, NovoCure's net income was $-49.48M. See NovoCure’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 503.98M	$ 537.84M	$ 535.03M	$ 494.37M	$ 351.32M	$ 248.07M
Cost of Revenue	$ 90.59M	$ 917.00K	$ -114.88M	$ 106.50M	$ 88.61M	$ 80.05M
Gross Profit	$ 413.39M	$ 422.97M	$ 420.15M	$ 387.87M	$ 262.71M	$ 168.02M
Operating Expense	$ 637.52M	$ 512.50M	$ -464.49M	$ 357.46M	$ 263.63M	$ 201.69M
Operating Income	$ -224.13M	$ -89.52M	$ -44.33M	$ 30.40M	$ -914.00K	$ -33.67M
Net Non Operating Interest Income Expense	$ 29.20M	$ 7.68M	$ -7.74M	$ -12.30M	$ -7.48M	$ -11.87M
Other Income Expense	$ -4.83M	$ -4.83M	$ -306.00K	$ 2.65M	$ -431.00K	$ -398.00K
Pretax Income	$ -185.76M	$ -81.85M	$ -52.08M	$ 18.10M	$ -8.82M	$ -45.94M
Tax Provision	$ 11.50M	$ 10.69M	$ 6.28M	$ -1.71M	$ -1.59M	$ 17.62M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -197.27M	$ -92.53M	$ -58.35M	$ 19.81M	$ -7.23M	$ -63.56M
Basic EPS	$ -1.86	$ -0.88	$ -0.56	$ 0.20	$ -0.07	$ -0.69
Diluted EPS	$ -1.86	$ -0.88	$ -0.56	$ 0.18	$ -0.07	$ -0.69
Basic Average Shares	$ 423.39M	$ 104.66M	$ 103.43M	$ 100.93M	$ 97.24M	$ 91.83M
Diluted Average Shares	$ 423.39M	$ 104.66M	$ 103.43M	$ 108.88M	$ 97.24M	$ 91.83M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 728.12M	$ 513.41M	$ -579.36M	$ 463.96M	$ 352.23M	$ 281.74M
Net Income From Continuing And Discontinued Operation	$ -197.27M	$ -92.53M	$ -58.35M	$ 19.81M	$ -7.23M	$ -63.56M
Normalized Income	$ -80.68M	$ 52.76M	-	$ 19.81M	$ -6.88M	$ -63.27M
Interest Expense	-	-	-	$ 17.58M	$ 13.72M	$ 13.49M
EBIT	$ -214.96M	$ -73.73M	$ -60.91M	$ 35.68M	$ 4.89M	$ -32.45M
EBITDA	$ -223.12M	$ -64.64M	$ -47.56M	$ 44.83M	$ 13.35M	$ -23.45M

Currency in USD

NovoCure Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing